NCT00579384View on ClinicalTrials.gov

A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Photosensitive Epilepsy
Interventions
DRUG

JNJ-26489112

Single oral dose of JNJ-26489112 up to 3000 mg on Day 2.

DRUG

Placebo

Single dose of placebo on Day 1, and a second single dose of placebo on Day 3.

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00579384 - A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy | Biotech Hunter | Biotech Hunter